MGIM
AMRX icon

M&G Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History

M&G Investment Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-221,447
Closed -$1.55M – 744
2021
Q1 		$1.55M Buy
+221,447
New +$1.23M ﹤0.01% 292

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

M&G Investment Management's AMRX Position: Q2 2021 in Review

M&G Investment Management sold out of Amneal Pharmaceuticals (AMRX) in Q2 2021, closing a stake of 221,447 shares — an estimated $1.55M sold.

M&G Investment Management first reported a position in AMRX in Q1 2021 and held it in 1 quarter. The position peaked at $1.55M in Q1 2021. 160 funds tracked by Wall St. Rank hold AMRX as of Q2 2021.

  • M&G Investment Management reported no remaining Amneal Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • M&G Investment Management sold 221,447 Amneal Pharmaceuticals shares in Q2 2021, an estimated $1.55M.
  • M&G Investment Management first reported a position in Amneal Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • M&G Investment Management's Amneal Pharmaceuticals position peaked at $1.55M in Q1 2021.
  • 160 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2021.

Based on M&G Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.